On 8 July 2026, European Commissioner for Health and Animal Welfare Olivér Várhelyi addressed a conference on the Animal Health Law, marking ten years since its adoption and five years since it began applying across the EU. Várhelyi highlighted the law's role in providing a modern, risk-based framework for disease prevention and response, but pointed to areas for improvement identified in a recently completed evaluation, including preparedness, implementation, biosecurity, and vaccination use.
Várhelyi noted that the EU has faced major animal disease challenges in recent years, including African swine fever, avian influenza, foot-and-mouth disease, sheep and goat pox, and lumpy skin disease, exacerbated by climate change, increased animal movements, global trade exposure, and geopolitical tensions. The evaluation, he said, confirms the law has provided a robust and coherent framework but found room for improvement in preparedness, on-the-ground implementation, awareness, and effective use of biosecurity and vaccination. The Commission has already asked the European Food Safety Authority to review categorisation criteria for vector-borne diseases and provide updated scientific opinions on disease listing and vaccination strategies. Várhelyi also referenced the Livestock Strategy adopted on 7 July 2026, which he said confirms the link between animal health and broader EU agricultural policies, framing spending on animal health as an investment in resilience, food security, and public health.
The speech contained no new legislative proposals or numerical targets but outlined concrete follow-up actions: the EFSA review and updated opinions, and a commitment to consult stakeholders on practical solutions. The policy orientation is towards strengthening prevention and preparedness within the existing legal framework, with a focus on science-based measures and flexible implementation. The tone was forward-looking and collaborative, emphasising partnership with member states, industry, and scientists. No prior coverage of this topic exists in the available record.
EU veterinary authorities and national governments will face pressure to strengthen implementation and resource allocation, potentially increasing administrative and financial burdens. EU livestock farmers and the broader agricultural sector stand to benefit from improved disease prevention and trade stability, but may face higher biosecurity compliance costs. The pharmaceutical and vaccine industry could see increased demand for veterinary vaccines if vaccination strategies are expanded. EU consumers and public health authorities gain from reduced zoonotic disease risks and antimicrobial resistance threats, though no immediate price or availability impacts are expected. Overall, the speech signals a moderate intensification of EU focus on animal health governance without immediate regulatory changes.